Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold
A novel class of SARS-CoV-2 main protease (M pro ) inhibitors derived from 1,5,6,7-tetrahydro-4 H -indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evalua...
Saved in:
Published in | Medicinal chemistry research Vol. 33; no. 1; pp. 151 - 163 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.01.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A novel class of SARS-CoV-2 main protease (M
pro
) inhibitors derived from 1,5,6,7-tetrahydro-4
H
-indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against M
pro
, two hits with IC
50
values bellow 60 μM were found with the best result of 27.31 μM for racemic amide
9m
. SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy. |
---|---|
AbstractList | A novel class of SARS-CoV-2 main protease (Mpro) inhibitors derived from 1,5,6,7-tetrahydro-4H-indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against Mpro, two hits with IC50 values bellow 60 μM were found with the best result of 27.31 μM for racemic amide 9m. SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy. A novel class of SARS-CoV-2 main protease (M pro ) inhibitors derived from 1,5,6,7-tetrahydro-4 H -indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against M pro , two hits with IC 50 values bellow 60 μM were found with the best result of 27.31 μM for racemic amide 9m . SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein–ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy. |
Author | Belenkaya, Svetlana V. Chirkova, Varvara Yu Khlebnicova, Tatyana S. Lakhvich, Fedor A. Piven, Yuri A. Zinovich, Veronica G. Shcherbakov, Dmitriy N. Puzanau, Raman M. |
Author_xml | – sequence: 1 givenname: Yuri A. orcidid: 0000-0003-3640-0981 surname: Piven fullname: Piven, Yuri A. email: piven.ya@gmail.com organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus – sequence: 2 givenname: Veronica G. surname: Zinovich fullname: Zinovich, Veronica G. organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus – sequence: 3 givenname: Dmitriy N. surname: Shcherbakov fullname: Shcherbakov, Dmitriy N. organization: Altay State University, State Research Center of Virology and Biotechnology “Vector” – sequence: 4 givenname: Varvara Yu surname: Chirkova fullname: Chirkova, Varvara Yu organization: Altay State University – sequence: 5 givenname: Svetlana V. surname: Belenkaya fullname: Belenkaya, Svetlana V. organization: State Research Center of Virology and Biotechnology “Vector” – sequence: 6 givenname: Raman M. surname: Puzanau fullname: Puzanau, Raman M. organization: Health Care Institution “National Anti-Doping Laboratory” – sequence: 7 givenname: Tatyana S. surname: Khlebnicova fullname: Khlebnicova, Tatyana S. organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus – sequence: 8 givenname: Fedor A. surname: Lakhvich fullname: Lakhvich, Fedor A. organization: Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus |
BookMark | eNp9kEtLAzEUhYMo-PwDrgJuG81rXkspagVFsOo2ZCZJmzImNUmV9g_4t40dQXDh6p7F-e695xyCXeedBuCU4HOCcXURMcacI0wZwoxUHG12wAEpCo5qQvFu1jhrWlC2Dw5jXGDMKsyLA_A59q_LVdIBSau0gkpHO3MjGNcuzbOOUDoF9bvsVzJZ76A30OkPOL18nKKxf0EU3i-Dh9bNbWuTDxG2MuZF2UpGxagcVSjpFOR8rYJHfIKsU3Lje8RRjgBjJ43xvToGe0b2UZ_8zCPwfH31NJ6gu4eb2_HlHeoobxKqDC5My2vV6aasidFSadqxVkmjeF0zQ7UiVGluVNlQzmrMVVNIpjrCWkMrdgTOhr356beVjkks_Cq4fFLQhjBCqpqW2VUPri74GIM2orNpmz8nsb0gWHzXLobaRa5dbGsXm4zSP-gy2FcZ1v9DbIBiNruZDr9f_UN9AZaXmCM |
CitedBy_id | crossref_primary_10_17650_2313_805X_2024_11_4_54_65 |
Cites_doi | 10.18097/PBMC20216703259 10.1111/febs.12936 10.1021/acs.jmedchem.0c01140 10.1182/blood-2008-04-151928 10.1016/j.softx.2015.06.001 10.1186/1756-0500-5-367 10.1002/jcc.21256 10.1126/science.1085658 10.1093/bioinformatics/btv082 10.1016/j.tetasy.2011.03.010 10.7150/ijbs.45472 10.1080/07391102.2021.1905559 10.1021/acsmedchemlett.0c00521 10.1021/acs.jmedchem.1c00598 10.1021/acs.chemrev.9b00055 10.1126/science.abl4784 10.1126/science.abb3405 10.1021/acs.jmedchem.1c01214 10.1039/d2md00344a 10.1016/j.bmc.2021.116521 10.1002/slct.201803469 10.1021/op300173z 10.1021/acsmedchemlett.1c00299 10.1021/acs.jctc.1c00645 10.1038/nrmicro.2016.81 10.1021/acsmedchemlett.2c00541 10.1186/1758-2946-3-33 10.1016/j.ejmech.2020.112711 10.1021/jp961710n 10.1021/acscentsci.1c00039 10.1021/ci500588j 10.1002/jmv.25681 10.1016/j.ejmech.2021.114046 10.1039/c5sc02678d 10.1021/jacs.1c08402 10.1073/pnas.2010470117 10.1016/j.steroids.2016.08.002 10.1016/j.molstruc.2022.133140 10.3390/v13020174 10.1002/wcms.1429 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
DBID | AAYXX CITATION 8FD FR3 M7Z P64 |
DOI | 10.1007/s00044-023-03174-z |
DatabaseName | CrossRef Technology Research Database Engineering Research Database Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts |
DatabaseTitle | CrossRef Biochemistry Abstracts 1 Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Biochemistry Abstracts 1 |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1554-8120 |
EndPage | 163 |
ExternalDocumentID | 10_1007_s00044_023_03174_z |
GroupedDBID | --- -56 -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 203 29M 29~ 2J2 2JN 2JY 2KG 2LR 2VQ 2~H 30V 4.4 406 408 409 40D 40E 5GY 5VS 67N 67Z 6NX 78A 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFFNX AFGCZ AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BAPOH BDATZ BGNMA BSONS CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBLON EBS EIOEI EJD EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HLICF HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M4Y MA- N2Q NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P2P PF0 PT4 QOR QOS R89 R9I RIG ROL RPX RSV S16 S1Z S27 S3A S3B SAP SBL SDH SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TSG TSK TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 YLTOR Z45 Z7U Z7V Z87 ZMTXR ZOVNA ~A9 ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION 8FD ABRTQ FR3 M7Z P64 |
ID | FETCH-LOGICAL-c249t-7f05fb48dce9681feade2c3bdafd4883f2ed12de4fd69243804d95a3dc13bf273 |
IEDL.DBID | U2A |
ISSN | 1054-2523 |
IngestDate | Tue Aug 12 22:14:40 EDT 2025 Tue Jul 01 01:53:36 EDT 2025 Thu Apr 24 22:57:13 EDT 2025 Fri Feb 21 02:41:35 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | indazol-4-ones SARS-CoV-2 1, 5, 6, 7-Tetrahydro-4 Molecular dynamics 3CL M Molecular docking |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c249t-7f05fb48dce9681feade2c3bdafd4883f2ed12de4fd69243804d95a3dc13bf273 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
ORCID | 0000-0003-3640-0981 |
PQID | 2913117826 |
PQPubID | 2043723 |
PageCount | 13 |
ParticipantIDs | proquest_journals_2913117826 crossref_citationtrail_10_1007_s00044_023_03174_z crossref_primary_10_1007_s00044_023_03174_z springer_journals_10_1007_s00044_023_03174_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20240100 2024-01-00 20240101 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 1 year: 2024 text: 20240100 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Heidelberg |
PublicationTitle | Medicinal chemistry research |
PublicationTitleAbbrev | Med Chem Res |
PublicationYear | 2024 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Wang, Sun, Wang, Wang, Liu, Zhang (CR24) 2019; 119 Shcherbakov, Baev, Kalinin, Dalinger, Chirkova, Belenkaya (CR13) 2022; 13 Okawa, Hideshima, Steed, Vallet, Hall, Huang (CR21) 2009; 113 Ye, Yuan, Yuen, Fung, Chan, Jin (CR2) 2020; 16 Stille, Tjutrins, Wang, Venegas, Hennecker, Rueda (CR11) 2022; 229 Andrianov, Nikolaev, Shuldov, Bosko, Anischenko, Tuzikov (CR33) 2022; 40 Liu, Liang, Xin, Ren, Tian, Ju (CR6) 2020; 206 Morris, Huey, Lindstrom, Sanner, Belew, Goodsell (CR37) 2009; 30 Sulimov, Shikhaliev, Pyankov, Shcherbakov, Chirkova, Ilin (CR34) 2021; 67 Sulur, Sharma, Ramakrishnan, Naidu, Merifield, Gill (CR22) 2012; 16 CR10 Piven, Yastrebova, Khamidullina, Scherbakov, Tatarskiy, Rusanova (CR32) 2022; 53 Anand, Ziebuhr, Wadhwani, Mesters, Hilgenfeld (CR4) 2003; 300 Alhossary, Handoko, Mu, Kwoh (CR23) 2015; 31 Muegge, Hu (CR25) 2023; 14 Strakova, Kumpiņa, Rjabovs, Lugiņina, Belyakov, Turks (CR29) 2011; 22 Valdes-Tresanco, Valdes-Tresanco, Valiente, Moreno (CR28) 2021; 17 O’Boyle, Banck, James, Morley, Vandermeersch, Hutchison (CR36) 2011; 3 Luttens, Gullberg, Abdurakhmanov, Vo, Akaberi, Talibov (CR19) 2022; 144 Hilgenfeld (CR5) 2014; 281 Chen, Liu, Guo (CR1) 2020; 92 Li, Li, Huang, Wu, Liu, Zhou (CR16) 2020; 117 Tian, Yue, Yang, Sang (CR30) 2019; 4 Chen, Gao, Liu, Li, Chen, Ma (CR15) 2023; 14 de Wit, van Doremalen, Falzarano, Munster (CR3) 2016; 14 Cannalire, Cerchia, Beccari, Di Leva, Summa (CR7) 2022; 65 Ghahremanpour, Tirado-Rives, Deshmukh, Ippolito, Zhang, Cabeza de Vaca (CR17) 2020; 11 Zhang, Stone, Deshmukh, Ippolito, Ghahremanpour, Tirado-Rives (CR18) 2021; 7 CR26 Owen, Allerton, Anderson, Aschenbrenner, Avery, Berritt (CR8) 2021; 374 Zhang, Lin, Sun, Curth, Drosten, Sauerhering (CR9) 2020; 368 Han, Goins, Arya, Shin, Maw, Hooper (CR12) 2022; 65 CR20 Hawkins, Cramer, Truhlar (CR39) 1996; 100 Abraham, Murtola, Schulz, Páll, Smith, Hess (CR27) 2015; 1-2 Aldeghi, Heifetz, Bodkin, Knapp, Biggin (CR40) 2016; 7 Sander, Freyss, von Korff, Rufener (CR35) 2015; 55 Ghosh, Raghavaiah, Shahabi, Yadav, Anson, Lendy (CR14) 2021; 64 Sousa da Silva, Vranken (CR38) 2012; 5 Khlebnicova, Piven, Baranovsky, Lakhvich, Shishkina, Zicane (CR31) 2017; 117 MM Ghahremanpour (3174_CR17) 2020; 11 R Cannalire (3174_CR7) 2022; 65 R Chen (3174_CR15) 2023; 14 ZW Ye (3174_CR2) 2020; 16 JK Stille (3174_CR11) 2022; 229 E de Wit (3174_CR3) 2016; 14 E Wang (3174_CR24) 2019; 119 YA Piven (3174_CR32) 2022; 53 J Tian (3174_CR30) 2019; 4 AW Sousa da Silva (3174_CR38) 2012; 5 GD Hawkins (3174_CR39) 1996; 100 A Alhossary (3174_CR23) 2015; 31 T Sander (3174_CR35) 2015; 55 MJ Abraham (3174_CR27) 2015; 1-2 L Zhang (3174_CR9) 2020; 368 I Muegge (3174_CR25) 2023; 14 A Luttens (3174_CR19) 2022; 144 D Shcherbakov (3174_CR13) 2022; 13 M Sulur (3174_CR22) 2012; 16 M Aldeghi (3174_CR40) 2016; 7 3174_CR10 Z Li (3174_CR16) 2020; 117 AK Ghosh (3174_CR14) 2021; 64 Y Liu (3174_CR6) 2020; 206 TS Khlebnicova (3174_CR31) 2017; 117 AV Sulimov (3174_CR34) 2021; 67 R Hilgenfeld (3174_CR5) 2014; 281 NM O’Boyle (3174_CR36) 2011; 3 CH Zhang (3174_CR18) 2021; 7 Y Chen (3174_CR1) 2020; 92 GM Morris (3174_CR37) 2009; 30 DR Owen (3174_CR8) 2021; 374 AM Andrianov (3174_CR33) 2022; 40 SH Han (3174_CR12) 2022; 65 I Strakova (3174_CR29) 2011; 22 MS Valdes-Tresanco (3174_CR28) 2021; 17 3174_CR20 Y Okawa (3174_CR21) 2009; 113 K Anand (3174_CR4) 2003; 300 3174_CR26 |
References_xml | – volume: 67 start-page: 259 year: 2021 end-page: 67 ident: CR34 article-title: Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease publication-title: Biomed Khim doi: 10.18097/PBMC20216703259 – volume: 281 start-page: 4085 year: 2014 end-page: 96 ident: CR5 article-title: From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design publication-title: FEBS J doi: 10.1111/febs.12936 – volume: 65 start-page: 2716 year: 2022 end-page: 46 ident: CR7 article-title: Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities publication-title: J Med Chem doi: 10.1021/acs.jmedchem.0c01140 – volume: 113 start-page: 846 year: 2009 end-page: 55 ident: CR21 article-title: SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK publication-title: Blood doi: 10.1182/blood-2008-04-151928 – volume: 1-2 start-page: 19 year: 2015 end-page: 25 ident: CR27 article-title: GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers publication-title: SoftwareX doi: 10.1016/j.softx.2015.06.001 – volume: 5 year: 2012 ident: CR38 article-title: ACPYPE – AnteChamber PYthon Parser interfacE publication-title: BMC Res Notes doi: 10.1186/1756-0500-5-367 – volume: 30 start-page: 2785 year: 2009 end-page: 91 ident: CR37 article-title: AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility publication-title: J Comput Chem doi: 10.1002/jcc.21256 – volume: 300 start-page: 1763 year: 2003 end-page: 7 ident: CR4 article-title: Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs publication-title: Science doi: 10.1126/science.1085658 – volume: 31 start-page: 2214 year: 2015 end-page: 6 ident: CR23 article-title: Fast, accurate, and reliable molecular docking with QuickVina 2 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv082 – volume: 22 start-page: 728 year: 2011 end-page: 39 ident: CR29 article-title: Resolution, absolute configuration, and synthetic transformations of 7-amino-tetrahydroindazolones publication-title: Tetrahedron Asymmetry doi: 10.1016/j.tetasy.2011.03.010 – volume: 16 start-page: 1686 year: 2020 end-page: 97 ident: CR2 article-title: Zoonotic origins of human coronaviruses publication-title: Int J Biol Sci doi: 10.7150/ijbs.45472 – volume: 40 start-page: 7555 year: 2022 end-page: 73 ident: CR33 article-title: Application of deep learning and molecular modeling to identify small drug-like compounds as potential HIV-1 entry inhibitors publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2021.1905559 – ident: CR10 – volume: 11 start-page: 2526 year: 2020 end-page: 33 ident: CR17 article-title: Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2 publication-title: ACS Med Chem Lett doi: 10.1021/acsmedchemlett.0c00521 – volume: 65 start-page: 2880 year: 2022 end-page: 904 ident: CR12 article-title: Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (SARS-CoV-2 3CL(pro)) publication-title: J Med Chem doi: 10.1021/acs.jmedchem.1c00598 – volume: 119 start-page: 9478 year: 2019 end-page: 508 ident: CR24 article-title: End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design publication-title: Chem Rev doi: 10.1021/acs.chemrev.9b00055 – volume: 374 start-page: 1586 year: 2021 end-page: 93 ident: CR8 article-title: An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19 publication-title: Science doi: 10.1126/science.abl4784 – volume: 368 start-page: 409 year: 2020 end-page: 12 ident: CR9 article-title: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors publication-title: Science doi: 10.1126/science.abb3405 – volume: 64 start-page: 14702 year: 2021 end-page: 14 ident: CR14 article-title: Indole chloropyridinyl ester-derived SARS-CoV-2 3CLpro inhibitors: enzyme inhibition, antiviral efficacy, structure-activity relationship, and X-ray structural studies publication-title: J Med Chem doi: 10.1021/acs.jmedchem.1c01214 – volume: 14 start-page: 9 year: 2023 end-page: 21 ident: CR15 article-title: Advances in research on 3C-like protease (3CL(pro)) inhibitors against SARS-CoV-2 since 2020 publication-title: RSC Med Chem doi: 10.1039/d2md00344a – volume: 53 start-page: 116521 year: 2022 ident: CR32 article-title: Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2021.116521 – volume: 4 start-page: 38 year: 2019 end-page: 41 ident: CR30 article-title: One-pot cleavage of aryl alkyl ethers by aluminum and iodine in acetonitrile publication-title: ChemistrySelect doi: 10.1002/slct.201803469 – volume: 16 start-page: 1746 year: 2012 end-page: 53 ident: CR22 article-title: Development of scalable manufacturing routes to AZD1981. Application of the Semmler–Wolff aromatisation for synthesis of the indole-4-amide core publication-title: Org Process Res Dev doi: 10.1021/op300173z – volume: 13 start-page: 140 year: 2022 end-page: 7 ident: CR13 article-title: Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors publication-title: ACS Med Chem Lett doi: 10.1021/acsmedchemlett.1c00299 – volume: 17 start-page: 6281 year: 2021 end-page: 91 ident: CR28 article-title: gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS publication-title: J Chem Theory Comput doi: 10.1021/acs.jctc.1c00645 – volume: 14 start-page: 523 year: 2016 end-page: 34 ident: CR3 article-title: SARS and MERS: recent insights into emerging coronaviruses publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro.2016.81 – volume: 14 start-page: 244 year: 2023 end-page: 50 ident: CR25 article-title: Recent advances in alchemical binding free energy calculations for drug discovery publication-title: ACS Med Chem Lett doi: 10.1021/acsmedchemlett.2c00541 – volume: 3 start-page: 33 year: 2011 ident: CR36 article-title: Open Babel: an open chemical toolbox publication-title: J Cheminform doi: 10.1186/1758-2946-3-33 – volume: 206 start-page: 112711 year: 2020 ident: CR6 article-title: The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2020.112711 – volume: 100 start-page: 19824 year: 1996 end-page: 39 ident: CR39 article-title: Parametrized models of aqueous free energies of solvation based on pairwise descreening of solute atomic charges from a dielectric medium publication-title: J Phys Chem doi: 10.1021/jp961710n – volume: 7 start-page: 467 year: 2021 end-page: 75 ident: CR18 article-title: Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations publication-title: ACS Cent Sci doi: 10.1021/acscentsci.1c00039 – volume: 55 start-page: 460 year: 2015 end-page: 73 ident: CR35 article-title: DataWarrior: an open-source program for chemistry aware data visualization and analysis publication-title: J Chem Inf Model doi: 10.1021/ci500588j – volume: 92 start-page: 418 year: 2020 end-page: 23 ident: CR1 article-title: Emerging coronaviruses: genome structure, replication, and pathogenesis publication-title: J Med Virol doi: 10.1002/jmv.25681 – volume: 229 start-page: 114046 year: 2022 ident: CR11 article-title: Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL(pro) covalent inhibitors publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2021.114046 – volume: 7 start-page: 207 year: 2016 end-page: 18 ident: CR40 article-title: Accurate calculation of the absolute free energy of binding for drug molecules publication-title: Chem Sci doi: 10.1039/c5sc02678d – volume: 144 start-page: 2905 year: 2022 end-page: 20 ident: CR19 article-title: Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses publication-title: J Am Chem Soc doi: 10.1021/jacs.1c08402 – volume: 117 start-page: 27381 year: 2020 end-page: 7 ident: CR16 article-title: Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2010470117 – ident: CR26 – volume: 117 start-page: 77 year: 2017 end-page: 89 ident: CR31 article-title: Synthesis of novel lupane triterpenoid-indazolone hybrids with oxime ester linkage publication-title: Steroids doi: 10.1016/j.steroids.2016.08.002 – ident: CR20 – volume: 65 start-page: 2716 year: 2022 ident: 3174_CR7 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.0c01140 – volume: 3 start-page: 33 year: 2011 ident: 3174_CR36 publication-title: J Cheminform doi: 10.1186/1758-2946-3-33 – volume: 281 start-page: 4085 year: 2014 ident: 3174_CR5 publication-title: FEBS J doi: 10.1111/febs.12936 – volume: 7 start-page: 467 year: 2021 ident: 3174_CR18 publication-title: ACS Cent Sci doi: 10.1021/acscentsci.1c00039 – volume: 14 start-page: 244 year: 2023 ident: 3174_CR25 publication-title: ACS Med Chem Lett doi: 10.1021/acsmedchemlett.2c00541 – volume: 368 start-page: 409 year: 2020 ident: 3174_CR9 publication-title: Science doi: 10.1126/science.abb3405 – volume: 55 start-page: 460 year: 2015 ident: 3174_CR35 publication-title: J Chem Inf Model doi: 10.1021/ci500588j – volume: 40 start-page: 7555 year: 2022 ident: 3174_CR33 publication-title: J Biomol Struct Dyn doi: 10.1080/07391102.2021.1905559 – volume: 17 start-page: 6281 year: 2021 ident: 3174_CR28 publication-title: J Chem Theory Comput doi: 10.1021/acs.jctc.1c00645 – volume: 206 start-page: 112711 year: 2020 ident: 3174_CR6 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2020.112711 – volume: 31 start-page: 2214 year: 2015 ident: 3174_CR23 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btv082 – volume: 117 start-page: 77 year: 2017 ident: 3174_CR31 publication-title: Steroids doi: 10.1016/j.steroids.2016.08.002 – volume: 14 start-page: 9 year: 2023 ident: 3174_CR15 publication-title: RSC Med Chem doi: 10.1039/d2md00344a – volume: 11 start-page: 2526 year: 2020 ident: 3174_CR17 publication-title: ACS Med Chem Lett doi: 10.1021/acsmedchemlett.0c00521 – volume: 67 start-page: 259 year: 2021 ident: 3174_CR34 publication-title: Biomed Khim doi: 10.18097/PBMC20216703259 – volume: 1-2 start-page: 19 year: 2015 ident: 3174_CR27 publication-title: SoftwareX doi: 10.1016/j.softx.2015.06.001 – volume: 13 start-page: 140 year: 2022 ident: 3174_CR13 publication-title: ACS Med Chem Lett doi: 10.1021/acsmedchemlett.1c00299 – volume: 53 start-page: 116521 year: 2022 ident: 3174_CR32 publication-title: Bioorg Med Chem doi: 10.1016/j.bmc.2021.116521 – volume: 30 start-page: 2785 year: 2009 ident: 3174_CR37 publication-title: J Comput Chem doi: 10.1002/jcc.21256 – volume: 14 start-page: 523 year: 2016 ident: 3174_CR3 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro.2016.81 – ident: 3174_CR20 doi: 10.1016/j.molstruc.2022.133140 – volume: 16 start-page: 1746 year: 2012 ident: 3174_CR22 publication-title: Org Process Res Dev doi: 10.1021/op300173z – volume: 100 start-page: 19824 year: 1996 ident: 3174_CR39 publication-title: J Phys Chem doi: 10.1021/jp961710n – volume: 22 start-page: 728 year: 2011 ident: 3174_CR29 publication-title: Tetrahedron Asymmetry doi: 10.1016/j.tetasy.2011.03.010 – volume: 113 start-page: 846 year: 2009 ident: 3174_CR21 publication-title: Blood doi: 10.1182/blood-2008-04-151928 – volume: 64 start-page: 14702 year: 2021 ident: 3174_CR14 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.1c01214 – volume: 300 start-page: 1763 year: 2003 ident: 3174_CR4 publication-title: Science doi: 10.1126/science.1085658 – volume: 119 start-page: 9478 year: 2019 ident: 3174_CR24 publication-title: Chem Rev doi: 10.1021/acs.chemrev.9b00055 – ident: 3174_CR10 doi: 10.3390/v13020174 – volume: 4 start-page: 38 year: 2019 ident: 3174_CR30 publication-title: ChemistrySelect doi: 10.1002/slct.201803469 – volume: 5 year: 2012 ident: 3174_CR38 publication-title: BMC Res Notes doi: 10.1186/1756-0500-5-367 – volume: 117 start-page: 27381 year: 2020 ident: 3174_CR16 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2010470117 – volume: 92 start-page: 418 year: 2020 ident: 3174_CR1 publication-title: J Med Virol doi: 10.1002/jmv.25681 – volume: 7 start-page: 207 year: 2016 ident: 3174_CR40 publication-title: Chem Sci doi: 10.1039/c5sc02678d – volume: 16 start-page: 1686 year: 2020 ident: 3174_CR2 publication-title: Int J Biol Sci doi: 10.7150/ijbs.45472 – volume: 374 start-page: 1586 year: 2021 ident: 3174_CR8 publication-title: Science doi: 10.1126/science.abl4784 – ident: 3174_CR26 doi: 10.1002/wcms.1429 – volume: 229 start-page: 114046 year: 2022 ident: 3174_CR11 publication-title: Eur J Med Chem doi: 10.1016/j.ejmech.2021.114046 – volume: 65 start-page: 2880 year: 2022 ident: 3174_CR12 publication-title: J Med Chem doi: 10.1021/acs.jmedchem.1c00598 – volume: 144 start-page: 2905 year: 2022 ident: 3174_CR19 publication-title: J Am Chem Soc doi: 10.1021/jacs.1c08402 |
SSID | ssj0037045 |
Score | 2.3144162 |
Snippet | A novel class of SARS-CoV-2 main protease (M
pro
) inhibitors derived from 1,5,6,7-tetrahydro-4
H
-indazol-4-ones was designed. Virtual screening based on... A novel class of SARS-CoV-2 main protease (Mpro) inhibitors derived from 1,5,6,7-tetrahydro-4H-indazol-4-ones was designed. Virtual screening based on... |
SourceID | proquest crossref springer |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 151 |
SubjectTerms | Biochemistry Biomedical and Life Sciences Biomedicine Bioorganic Chemistry CAD Computer aided design Inorganic Chemistry Mathematical analysis Medicinal Chemistry Molecular docking Molecular dynamics Original Research Article Pharmacology/Toxicology Protease inhibitors Proteinase inhibitors Severe acute respiratory syndrome coronavirus 2 Synthesis |
Title | Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold |
URI | https://link.springer.com/article/10.1007/s00044-023-03174-z https://www.proquest.com/docview/2913117826 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9swDBW29rphn1i6ruCh6GUmENuSIx_TolnQokWxNkN3MmxTwgIE9lB7h-QP7G-PUuwYG7YBPflgWTZMiXwUyUchjimMypKRNyZSKWQtaZHtuEZlLRUUGpsXzlG8uk7mC3lxr-67orCmz3bvQ5JeU--K3XzwEdnGIC_EicTNU7Gv2Hd3iVyLaNrr33gy9q2JGThIjNjP6kpl_j7H7-ZowJh_hEW9tZm9EM87mAjTrVxfiiemeiVObrY80-sA7oayqSaAE7gZGKjXr8XPvlcDOgJIAvJpGgE064rxXrNsIK8IBqJvqC0wvIbb6edbPKu_YARX_JGwrL4ti6XrxwPO2hHw0DBQQRJMsDUt66k1PdQo5-g8-029Qol1ZaApc2vrFb0Ri9n53dkcu44LWLIb1uLEjpUtpKbSpIkOrcumjsq4oNwS7_TYRoaFS0ZaSthxi_VYUqrymMowLiwjobdir-L3vBOQxibRVjNAK4xMtdJkGVlYbXwkMQ5HIux_fFZ2dOSuK8Yq2xEpe2FlLKzMCyvbjMTH3TPft2Qc_x192Msz6zZmk0Wp4xdiWJSMRNDLeLj979kOHjf8vXjGS5PBbBRuD2wOxV778MN8YAjTFkdifzo7Pb12109fL8-P_Ar-BTG_6js |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VcoBLRfkRS0vxAXohI20cJ-scOKwK1ZZ2q4ruot5CEttipVVSNalQ9gV4ER6UsTfZCARIHHqO41iZ8cw39sw3AK-Vz_OckDdGIgyRrKRB8uMSQ2NUpnxt0swGitPzaDIXH6_Cqy340dXCuGz37krSWepNsZu7fETyMUiKOBK4alMpT3XzjQK16t3Je5LqG86PP8yOJtj2EsCcAowaR2YYmkxIles4kr6xecI8DzKVGkU6HBiuadlKC6MiCkkCORQqDtNA5X6QGfLxNO89uE_gQ9q9M-fjzt4Ho6FrhUxARSCnuK4tzfnzmn91fz2m_e0a1nm340ew08JSNl7r0S5s6eIxHF6sea0bj836Mq3KY4fsome8bp7A9643BFrCScWUSwvxWNUUhC-rRcXSQrGeWJyVhhGcZ5fjT5d4VH5Gzqa0SLYovi6yhe3_w6x3VYyG-l7oRd4Ia12TXWzUTYligvYkYVUuUWBZaFblqTHlUj2F-Z1I5RlsF_Sd58DiQEfSSAKEmRaxDKUyhGSM1O7mMvAH4Hc_Pslb-nPbhWOZbIibnbASElbihJWsBvB28871mvzjn6P3O3kmrSGoEh5bPiOCYdEAvE7G_eO_z_bi_4a_ggeT2fQsOTs5P92Dh5yg1_qgaB-265tb_ZKgU50dOM1l8OWut8pP4kElmg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkRAXVP7EQgEfoBcy6sZxss6Bw6pltaW0WtEu6i0ksUddaZVUTVCVfQFeh0dk7E02AgESh57jOD8z9nzjmfmGsTfaF3lOyBsiGYZAuyQC2XEFIaLOtG8wzayjeHIaTefy40V4scV-dLUwLtu9C0muaxosS1NR719p3N8UvrlAJJC9AVLKkYRVm1Z5bJobctqq90eHJOG3Qkw-nB9Moe0rADk5GzWMcBhiJpXOTRwpH23OsMiDTKeoSZ8DFIY-QRuJOiL3JFBDqeMwDXTuBxmSvad577C70lYf0wqai3G39wejoWuLTKBFgiAfry3T-fM7_2oKe3z7W0jWWbrJDnvQQlQ-XuvUQ7Zlikdsb7bmuG48ft6XbFUe3-Oznv26ecy-d30iwJJPaq5diojHq6YgrFktKp4Wmvck47xETtCen40_n8FB-QUEP6GX5IvicpEtbC8gbi2t5jTU90Iv8kZQm5r2yEZflyCnYE8VVuUSJJSF4VWeIpZL_YTNb0UqT9l2Qc95xngcmEihInCYGRmrUGkkVIPKuChm4A-Y3_34JG-p0G1HjmWyIXF2wkpIWIkTVrIasHebe67WRCD_HL3byTNpN4UqEbHlNiJIFg2Y18m4v_z32Z7_3_DX7N7scJJ8Ojo9fsHuC0Jh9szIF7tsu77-Zl4SiqqzV05xOft62yvlJ8_wKc8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Computer-aided+design%2C+synthesis+and+evaluation+of+new+SARS-CoV-2+Mpro+inhibitors+based+on+1%2C5%2C6%2C7-tetrahydro-4H-indazol-4-one+scaffold&rft.jtitle=Medicinal+chemistry+research&rft.au=Piven%2C+Yuri+A.&rft.au=Zinovich%2C+Veronica+G.&rft.au=Shcherbakov%2C+Dmitriy+N.&rft.au=Chirkova%2C+Varvara+Yu&rft.date=2024-01-01&rft.issn=1054-2523&rft.eissn=1554-8120&rft.volume=33&rft.issue=1&rft.spage=151&rft.epage=163&rft_id=info:doi/10.1007%2Fs00044-023-03174-z&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00044_023_03174_z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1054-2523&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1054-2523&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1054-2523&client=summon |